Latest press and news

Jan 21

Press Releases

Last patient treated in the world’s first interventional trial with 3D microtumors as guide for choice of cancer treatment.

Jan 5

Press ReleasesPress Releases Regulatory

2cureX appoints Fernando Andreu, an international Biotech executive, as new CEO

Nov 26

Press Releases Regulatory

2cureX publishes interim report for the third quarter of 2020.

Nov 5

Press Releases Regulatory

Announcement from 2cureX extra general meeting

Oct 14

Press Releases Regulatory

Notice of extraordinary general meeting in 2cureX AB

Oct 1

Press Releases Regulatory

Last patient successfully enrolled in the world’s first interventional trial with 3D microtumors as guide for choice of cancer treatment.

Sep 14

Press Releases

2cureX launches world’s first CE-marked microtumor test service

Aug 27

Press Releases Regulatory

2cureX AB (“2cureX”) hereby publishes the interim report for the first half of 2020